Singer Nicholas Jason
- SEC CIK
- 0001828224
No open-market purchases or sales filed in the past year.
Current role at each company
- ERNA Ernexa Therapeutics Inc.Directoras of Dec 6, 2022
- OTRA OTR Acquisition Corp.Chief Executive Officeras of May 20, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Singer Nicholas Jason as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ERNA Ernexa Therapeutics Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2022 (view filing)6:52 PM ET | Dec 2 | 4 days | Singer Nicholas JasonDirector | PPurchase | +283.3K | $3.28 | +$929.2K | New position266.2K after | 2 lots |
| Dec 6, 2022 (view filing)6:52 PM ET | Dec 2 | 4 days | Singer Nicholas JasonDirector | PPurchaseCommon Stock, par value $0.005 per share | +566.6K | $0.125 | +$70.8K | –424.9K after | Derivative2 lots |